Ie-Ming Shih is a notable inventor based in Clarksville, MD (US). He has made significant contributions to the field of medical diagnostics and treatment through his innovative research. With a total of 2 patents, his work focuses on developing small molecule compounds and diagnostic methods that have the potential to impact various medical conditions.

Latest Patents

One of Ie-Ming Shih's latest patents is centered around small molecule compounds targeting the PBX1 transcriptional complex. This invention provides compounds for inhibiting PBX1-DNA interaction in mammalian cells, which can be utilized in treating cancers, developmental disorders, inflammatory disorders, autoimmune diseases, and neuro-degenerative disorders. Another significant patent involves a DNA integrity assay (DIA) for cancer diagnostics, utilizing confocal fluorescence spectroscopy. This method determines the size distribution of DNA molecules in samples containing cell-free nucleic acid, aiding in cancer detection through single molecule DNA integrity analysis.

Career Highlights

Ie-Ming Shih is affiliated with Johns Hopkins University, where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical diagnostics and therapeutic strategies.

Collaborations

Some of his notable coworkers include Alexander Stoeck and Mark Vaal, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Ie-Ming Shih's contributions to the field of medical research through his patents and collaborations highlight his role as an influential inventor. His work has the potential to lead to significant advancements in the treatment and diagnosis of various medical conditions.